ABO-incompatible kidney transplantation: Current practice and the decade ahead

Current Opinion in Organ Transplantation

Volumn 15, Issue 4, 2010, Pages 526-530

  Crew, Russell J ^a   Ratner, Lloyd E ^a  

^a Howard Hughes Medical Institute   (United States)

Author keywords

ABO incompatible kidney transplantation; antibody mediated rejection; plasmapheresis

Indexed keywords

BETA GALACTOSIDASE; CARBOHYDRATE ANTIGEN; CD20 ANTIBODY; COMPLEMENT MEMBRANE ATTACK COMPLEX; ECULIZUMAB; FIBRINOGEN; FRESH FROZEN PLASMA; HEMAGGLUTININ; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; RITUXIMAB; STEROID; TACROLIMUS; BLOOD GROUP ABO SYSTEM;

ACUTE GRAFT REJECTION; BLOOD GROUP ABO INCOMPATIBILITY; DRUG WITHDRAWAL; ENDOTHELIUM CELL; ERYTHROCYTE; EX VIVO STUDY; GRAFT SURVIVAL; HUMAN; HYPOCALCEMIA; IMMUNOADSORPTION; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MEDICAL PRACTICE; NONHUMAN; OUTCOME ASSESSMENT; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATIENT SELECTION; PLASMAPHERESIS; PRURITUS; REVIEW; SPLENECTOMY; URTICARIA; XENOTRANSPLANTATION; ANIMAL; BLOOD; BLOOD GROUP ABO SYSTEM; DONOR; GRAFT REJECTION; HISTOCOMPATIBILITY; HOSPITAL ADMISSION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; PROCEDURES; SUPPLY AND DISTRIBUTION; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME; TRENDS;

ABO BLOOD-GROUP SYSTEM; ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; PATIENT SELECTION; TISSUE DONORS; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME; WAITING LISTS;

EID: 77955228204     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32833bfbba     Document Type: Review

References (28)

1. Alexandre GP, Squifflet JP, De Bruyè re M, et al. Present experience in a series of 26 ABO incompatible live donor allografts. Transplant Proc 1987; 19:4538-4542.
2. Takahashi K. Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for AAMR due to ABO-blood-grouprelated antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol 2007; 11:128-141.
3. Tanabe K. Japanese experience of ABO-incompatible living kidney transplantation. Transplantation 2007; 84:S4-7.
4. Toki D, Ishida H, Horita S, et al. Blood groupOrecipients associated with early graft deterioration in living ABO-incompatible kidney transplantation. Transplantation 2009; 88:1186-1193.
5. Just SA, Marcussen N, Sprogøe U, et al. Acute antibody-mediated rejection after ABO-incompatible kidney transplantation treated successfully with antigen-specific immunoadsorption. Nephrol Dial Transplant 2010; 25: 310-313.
6. Toki D, Ishida H, Shimizu T, et al. Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors. Am J Transpl 2009; 9:567-577.
7. Gloor JM, Cosio FG, Rea DJ, et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transpl 2006; 6:1841-1847.
8. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transpl 2009; 9:2520-2531.
9. Ratner LE, Rana A, Ratner ER, et al. The altruistic unbalanced paired kidney exchange: proof of concept and survey of potential donor and recipient attitudes. Transplantation 2010; 89:15-22.
10. Kobayashi T, Saito K. A series of surveys on assay for anti-A/B antibody by Japanese ABO-incompatible Transplantation Committee. Xenotransplantation 2006; 13:136-140.
11. Kumlien G, Wilpert J, Safwenberg J, Tydén G. Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007; 84:S17-19.
12. Krishnan NS, Fleetwood P, Higgins RM, et al. Application of flow cytometry to monitor antibody levels in ABO incompatible kidney transplantation. Transplantation 2008; 86:474-477.
13. Tobian AA, Shirey RS, Montgomery RA, et al. Therapeutic plasma exchange reduces ABO titers to permit ABO-incompatible renal transplantation. Transfusion 2009; 49:1248-1254.
14. Vallia PV, Puga Yung G, Fehr TV, et al. Changes of circulating antibody levels induced by ABO antibody adsorption for ABO-incompatible kidney transplantation. Am J Transpl 2009; 9:1072-1080.
15. Balint B, Pavlovic M, Jevtic M, et al. Simple ''closed-circuit'' group-specific immunoadsorption system for ABO-incompatible kidney transplants. Transfus Apher Sci 2007; 36:225-233.
16. Gunilla K, Ullström L, Losvall A, et al. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006; 46:1568-1575.
17. Genberg H, Kumlien G, Wennberg L, et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 2008; 85:1745-1754.
18. Ramos EJ, Pollinger HS, Stegall MD, et al. The effect of desensitization protocols on human splenic B-cell populations in vivo. Am J Transpl 2007; 7:402-407.
19. Toki D, Ishida H, Horita S, et al. Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients. Transpl Int 2009; 22:447-454.
20. Tanabe K, Ishida H, Shimizu T, et al. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated nonsplenectomy preconditioning regimens. Contrib Nephrol 2009; 162:61-74.
21. Segev DL, Simpkins CE, Warren DS, et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005; 5:2570-2575.
22. Ishida H, Miyamoto N, Shirakawa H, et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-single center analysis. Am J Transpl 2007; 7:827-831.
23. Oettl T, Zuliani E, Gaspert A, et al. Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplant: high rate of mild cellular rejection. Transplantation 2010; 89:702-706.
24. Numberger J, Philip T, Witzke O, et al. Eculizumab for atypical hemolytic- uremic syndrome. N Engl J Med 2009; 360:542-544.
25. Locke JE, Magro CM, Singer AL, et al. The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transpl 2009; 9:231-235.
26. Kobayashi T, Liu D, Ogawa H, et al. Removal of blood group A/B antigen in organs by ex vivo and in vivo administration of endo-beta-galactosidase (ABase) for ABO-incompatible transplantation. Transpl Immunol 2009; 20:132-138.
27. Hasegawa Y, Kato Y, Kaneko MK, et al. Neutralization of blood group A-antigen by a novel anti-A antibody: overcoming ABO-incompatible solidorgan transplantation. Transplantation 2008; 85:378-385.
28. Dehoux JP, Gianello P. Accommodation and antibodies. Transpl Immunol 2009; 21:106-110.